CANCER CHEMOTHERAPY AND PHARMACOLOGY

CANCER CHEMOTHERAPY AND PHARMACOLOGY Journal

publication venue for

A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies. 87:599-611. 2021
Safety profile of nivolumab administered as 30-min infusion: analysis of data from CheckMate 153. 81:679-686. 2018
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma. 62:347-354. 2008
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane((R))) on three treatment schedules in patients with solid tumors. 60:759-766. 2007
Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer. 51:328-336. 2003
Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing. 47:373-379. 2001
PHASE-II TRIAL AND PHARMACOKINETIC ASSESSMENT OF INTRAVENOUS MELPHALAN IN PATIENTS WITH ADVANCED PROSTATE-CANCER. 31:363-368. 1993

category

ONCOLOGY Web of Science Category
PHARMACOLOGY & PHARMACY Web of Science Category

International Standard Serial Number (ISSN)

0344-5704

Electronic International Standard Serial Number (EISSN)

1432-0843

journal abbreviation

CANCER CHEMOTH PHARM